FormWeb • valGANciclovir

Approved Hospital Formulary

Formulary Addition Requisition (Position 1)

Demo Page

valGANciclovir

Drug Name	Form	Strength	Non-Formulary	Restricted	Renal Dosing	REMS	Therapeutic Interchange	Notes
ValGANciclovir Hydrochloride	POWDER FOR RECONSTITUTION, ORAL	50 mg/mL
Valcyte	TABLET, ORAL	450 mg

VIEW MORE Nucleosides and Nucleotides

Additional Information:

Drug Name	Common Side Effects
valganciclovir	GI: nausea, vomiting, diarrhea fever muscle twitching

Last updated: Sep. 23, 2022

Black Box Warning: Hematologic Toxicity; Impairment of Fertility; Fetal Toxocity; Mutagenesis & Carcinogenesis
Do Not Crush: Tablet - Note: Teratogenic and irritant potential (i,b)
Restricted: ID approval needed. Exception: Unrestricted use for solid organ and bone marrow transplant patients.

For further information regarding Formweb
please contact support@rpharmy.com.